56 completed, 8 unknown, 4 terminated, 2 recruiting. 27 Phase 3, 9 Not applicable, 7 Phase 4, 6 Phase 2, 5 Phase 1.
Follow Duodenal Ulcer: new trials by email Literature Review of Duodenal Ulcer trials Research Report on Duodenal Ulcer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 to Evaluate the Efficacy and Safety of DWP14012 in Patients With Gastric Ulcer DWP14012 40mg (Fexuprazan), Lansoprazole 30mg - Gastric Ulcer | Phase 3 | Not yet recruiting | Daewoong Pharmaceutical Co. LTD. | 384 | 2026-10-15 | 2026-07-28 |
| Efficacy and Safety of Esomeprazole 40 mg IV in Post-Surgical Patients Admitted to the ICU Esomeprazole - Stress Ulcers, Reflux Episodes | Recruiting | Asian Institute of Gastroenterology, India | 50 | 2026-02-23 | 2026-10-05 | |
| Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg/10 ml Oral Suspension and Riopan 800 mg Chewable Tablets in Healthy Volunteers Antareit - Heartburn, Acid-dependent Diseases of the Gastrointestinal Tract | Not applicable | Unknown | Valenta Pharm JSC | 50 | 2024-04-25 | 2024-07-22 |
| Coated or Chewable Aspirin and a Hybrid Strategy to Mitigate Adverse Effects of Air Pollution in Stable Atherosclerotic Disease Enteric-coated aspirin, Plain aspirin, Hybrid strategy - Atherosclerotic Cardiovascular Disease, Coronary Artery Disease | Not applicable | Recruiting | Rajaie Cardiovascular Medical and Research Center | 3000 | 2024-03-06 | 2025-03-19 |
| A Study to Evaluate the Pharmacokinetics and Safety Between Single Administration of "BR6002" and Coadministration of "BR6002A" and "BR6002B" Under Fasting Conditions in Healthy Adult Volunteers BR6002A, BR6002B, BR6002 - Gastric or Duodenal Ulcers | Phase 1 | Completed | Boryung Pharmaceutical Co., Ltd | 40 | 2023-07-14 | 2023-12-05 |
| A Study to Evaluate the Pharmacokinetics and Safety Between Single Administration of "BR6002" and Coadministration of "BR6002A" and "BR6002B" Under Fed Conditions in Healthy Adult Volunteers BR6002A, BR6002B, BR6002 - Gastric or Duodenal Ulcer | Phase 1 | Completed | Boryung Pharmaceutical Co., Ltd | 40 | 2023-07-13 | 2023-11-18 |
| Optimizing Stress Ulcer Prophylaxis Practices and Reducing Associated Costs in Intensive Care Units: a Nonrandomized Controlled Study stress ulcer prophylaxis - Stress Ulcer | Not applicable | Completed | Altinbas University | 196 | 2023-06-01 | 2024-09-19 |
| Pharmacist-Driven Stress Ulcer Prophylaxis Minimization in the Intensive Care Unit To evaluate the effectiveness and safety of a pharmacist-driven protocol to discontinue stress ulcer prophylaxis in ICU patients when it is no longer indicated according to pre-defined criteria. - Stress Ulcer | Completed | Methodist Health System | 120 | 2023-05-13 | 2026-03-23 | |
| A Study to Evaluate the Drug-drug Interaction and Safety Between "BR6001-1" and "BR6001-2" BR6001-1, BR6001-2 - Gastric or Duodenal Ulcer | Phase 1 | Completed | Boryung Pharmaceutical Co., Ltd | 30 | 2023-03-30 | 2024-02-01 |
| Systems Biology of Gastrointestinal and Related Diseases Ulcerative Colitis, Crohn Disease | Terminated | Viome | 17 | 2022-11-11 | 2023-12-15 | |
| To Develop Methods for the Rehabilitation of Chronic Gastroduodenal Pathology in Children. Enteral oxygen therapy - Gastritis Chronic, Gastroduodenitis | Not applicable | Active not recruiting | Tashkent State Medical University (Tashkent Pediatric Medical Institute), Uzbekistan | 320 | 2022-04-30 | 2025-05-21 |
| Efficacy and Safety of LXI-15028 Comparing With Lansoprazole in the Treatment of Duodenal Ulcer LXI-15028 50mg group, Lansoprazole 30mg group - Duodenal Ulcer | Phase 3 | Completed | Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. | 400 | 2021-10-18 | 2023-04-25 |
| Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg Chewable Tablets and Riopan 800 mg Chewable Tablets in Healthy Volunteers Magaldrate - Heartburn, Acid-dependent Diseases of the Gastrointestinal Tract | Not applicable | Completed | Valenta Pharm JSC | 40 | 2021-07-07 | 2024-08-14 |
| A Study of Pariet to Prevent Gastric and Duodenal Ulcer Associated With Low-aspirin in Korean Participants With a History of Gastric and Duodenal Ulcer Pariet - Stomach Ulcer, Duodenal Ulcer | Completed | Eisai Korea Inc. | 676 | 2020-07-23 | 2022-11-22 | |
| Stress Ulcer Prophylaxis Versus Placebo in Critically Ill Infants With Congenital Heart Disease Famotidine, Placebo - Congenital Heart Disease, Upper Gastrointestinal Bleeding | Phase 4 | Completed | Boston Children's Hospital | 70 | 2019-03-10 | 2022-09-21 |
| A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer D961H capsule 10mg, D961H sachet 10mg - Reflux Esophagitis, Gastric Ulcer | Phase 3 | Completed | AstraZeneca | 50 | 2018-07-24 | 2026-03-04 |
| The Efficacy and Safety of Ilaprazole/Doxycycline-based Bismuth-containing Quadruple Therapy on Hp Infected Duodenal Ulcers Doxycycline Hyclate Enteric-Coated Capsules, Amoxicillin Capsules, Ilaprazole Enteric-Coated Tablets - Duodenal Ulcer Due to Helicobacter Pylori | Phase 4 | Completed | The Third Xiangya Hospital of Central South University | 184 | 2017-12-13 | 2022-03-02 |
| Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori Infection TAK-438, Lansoprazole, TAK-438 Placebo - Duodenal Ulcer | Phase 3 | Completed | Takeda | 533 | 2017-04-05 | 2020-06-12 |
| Special Drug Use Surveillance of Vonoprazan for "Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: Long-term Use" Vonoprazan - A History of Gastric or Duodenal Ulcers | Completed | Takeda | 1304 | 2016-09-01 | 2023-06-07 | |
| Special Drug Use Surveillance of Vonoprazan for "Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin: Long-term Use" Vonoprazan - Gastric or Duodenal Ulcers | Completed | Takeda | 1119 | 2016-09-01 | 2020-03-11 |
Showing 20 of 72. Sign in to see all of them.
Stomach Ulcer (43) · Peptic Ulcer (7) · Esophagitis, Peptic (6) · Gastritis (6) · Gastroesophageal Reflux (5) · Gastrointestinal Hemorrhage (4) · Stomach Neoplasms (4) · Dyspepsia (3) · Osteoarthritis (3) · Arthritis, Rheumatoid (2) · Coronary Artery Disease (2) · Gastrointestinal Diseases (2) · Heartburn (2) · Helicobacter Infections (2)
Duodenal Diseases (72) · Intestinal Diseases (72) · Stomach Diseases (72) · Digestive System Diseases (71) · Gastrointestinal Diseases (70) · Peptic Ulcer (65) · Gastroenteritis (13) · Pathological Conditions, Signs and Symptoms (13) · Esophageal Diseases (10) · Signs and Symptoms (9) · Esophagitis (7) · Pathologic Processes (7) · Deglutition Disorders (6) · Digestive System Neoplasms (6) · Esophageal Motility Disorders (6)
Lansoprazole (16) · 1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine (12) · Esomeprazole (7) · Rabeprazole (7) · Amoxicillin (5) · Clarithromycin (4) · Omeprazole (4) · Metronidazole (3) · ilaprazole (3) · Aspirin (2) · Clopidogrel (2) · Gefarnate (2) · Celecoxib (1) · Famotidine (1) · Furazolidone (1)
Takeda (18) · AstraZeneca (15) · Boryung Pharmaceutical Co., Ltd (3) · Eisai Co., Ltd. (3) · Hamamatsu University (3) · Livzon Pharmaceutical Group Inc. (3) · National Taiwan University Hospital (2) · The Catholic University of Korea (2) · Valenta Pharm JSC (2) · Altinbas University (1) · Asian Institute of Gastroenterology, India (1) · Bakirkoy Dr. Sadi Konuk Research and Training Hospital (1) · Boston Children's Hospital (1) · Cogentus Pharmaceuticals (1) · Daewoong Pharmaceutical Co. LTD. (1)
Japan (29) · South Korea (11) · United States (8) · China (6) · Taiwan (5) · Russia (4) · Australia (2) · Bulgaria (2) · Canada (2) · Czechia (2) · Finland (2) · Germany (2) · Indonesia (2) · Italy (2) · Mexico (2)
Shigeru Yoshida, MD (4) · Jyh-Chin Yang, M.D. (2) · Naotsugu Oyama (2) · Nobuyuki Sugisaki (2) · S R Lin, M.D (2) · Anders Perner, MD, PhD (1) · Angelo Zullo, MD (1) · Ben D Albert, MD (1) · Christof Kreutz, MD (1) · Dennis A Ruff, MD (1)
PMID 28988197, PMID 29196436, PMID 12641522, PMID 17916545, PMID 20230209, PMID 20679904, PMID 20925534, PMID 21415072, PMID 21726257, PMID 22070512, PMID 22591121, PMID 23188121, PMID 23530709, PMID 24326741, PMID 25574111, PMID 27012778, PMID 27093939, PMID 27891632, PMID 29499622, PMID 30354950, PMID 30863936, PMID 31282567, PMID 31321771, PMID 31441031, PMID 31938829, PMID 32600393, PMID 35122105, PMID 36264125, PMID 38240536, PMID 38910891, PMID 39085080, PMID 39378042
2018 (1)